Paige Parrack to Humans
                            
                            
                                This is a "connection" page, showing publications Paige Parrack has written about Humans.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.182
         
        
        
     
 
    
        
        - 
            PAX1 expression in thymic epithelial neoplasms and morphologic mimics. Hum Pathol. 2023 12; 142:7-14.
            
            
                Score: 0.048
            
         
        
        - 
            Liver Pathology Related to Onco-Therapeutic Agents. Surg Pathol Clin. 2023 Sep; 16(3):499-518.
            
            
                Score: 0.047
            
         
        
        - 
            GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics. Am J Surg Pathol. 2023 04 01; 47(4):453-460.
            
            
                Score: 0.046
            
         
        
        - 
            Predicting recurrence in pancreatic neuroendocrine tumours: role of ARX and alternative lengthening of telomeres (ALT). Histopathology. 2023 Oct; 83(4):546-558.
            
            
                Score: 0.012
            
         
        
        - 
            Quantitative p53 immunostaining aids in the detection of prevalent dysplasia. J Clin Pathol. 2023 Sep; 76(9):582-590.
            
            
                Score: 0.012
            
         
        
        - 
            Use of Immunohistochemistry to Determine Expression of Rab5 Subfamily of GTPases in Mature and Developmental Brains. Methods Mol Biol. 2021; 2293:265-271.
            
            
                Score: 0.010
            
         
        
        - 
            c-Cbl mediates the degradation of tumorigenic nuclear ?-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors. Oncotarget. 2016 11 01; 7(44):71136-71150.
            
            
                Score: 0.007